Bladder Cancer Warning on Pioglitazone an Anti-diabetic Drug

It is an insulin sensitizer, but unfortunately has been seen to have bad effect on urinary bladder in long term use.
Cannot the harmful effect producing fraction of molecule be silenced in some way, so that a good drug will remain in the armour of the physicians?

Amplify’d from

The FDA has approved updated label information for pioglitazone (Actos) and medications that contain it, following its warning in June about bladder cancer risk with the drug.

The new labeling, released Friday, warns that use of pioglitazone for more than a year may increase the risk of bladder cancer, a finding based on an interim analysis of an epidemiological study.

Pioglitazone is the second medication in the thiazolidinedione (TZD) class to be associated with serious side effects. Last fall, use of rosiglitazone (Avandia) was severely restricted in the U.S. because of concerns over heart attack risk.




, , ,

  1. Leave a comment

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: